Prevalence, Clinical Associations, and Outcomes of Cardiorenal Anemia Syndrome Among Patients With Heart Failure Attending a Tertiary Hospital in Dodoma, Tanzania: A Prospective Observational Cohort Study
Prävalenz, klinische Assoziationen und Outcomes des Cardiorenal-Anämie-Syndroms bei Patient:innen mit Herzinsuffizienz in einem Tertiärkrankenhaus in Dodoma, Tansania: prospektive Beobachtungskohorte
Health Science Reports · 2026-07 · 9 (7)
DOI: 10.1002/hsr2.72809 ↗Auf einen Blick
Bei 268 Patient:innen mit chronischer Herzinsuffizienz war das Cardiorenal-Anämie-Syndrom häufig. Es war mit einer höheren Gesamtmortalität verbunden.
Fragestellung
Wie häufig ist das Cardiorenal-Anämie-Syndrom bei Patient:innen mit Herzinsuffizienz, und mit welchen klinischen Faktoren und Outcomes ist es assoziiert?
Methode
Prospektive Beobachtungskohortenstudie in der kardiologischen Ambulanz des Benjamin Mkapa Hospital von August 2023 bis April 2024; adulte Patient:innen mit chronischer Herzinsuffizienz; logistische und Cox-Regression.
Ergebnisse
268 Patient:innen; medianes Alter 56,5 Jahre; 57,5 % Frauen. Prävalenz 41,8 % (112/268). Gesamtmortalität höher bei CRAS: HR 1,96 (95 %-KI 1,30–3,01).
Einschränkungen
Einzentrische Studie.
Schlussfolgerung der Autor:innen
Die Studie zeigte, dass CRAS häufig ist und mit einem erhöhten Risiko für die Gesamtmortalität verbunden ist. Adipositas, Eisenmangel, fortgeschrittene NYHA-Stadien und Diabetes mellitus erfordern besondere Aufmerksamkeit.
Kernaussagen
- CRAS-Prävalenz: 41,8 % (112/268)
- Höhere Gesamtmortalität bei CRAS: HR 1,96
- Assoziiert mit Adipositas, Eisenmangel, NYHA III/IV und Diabetes mellitus
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Kohortenstudie in der Zeitschrift Health Science Reports, online erschienen am 13.07.2026. Verfasst von Gidion Edwin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine and Dentistry University of Dodoma Dodoma Tanzania. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background and Aims Cardiorenal anemia syndrome (CRAS) is a common complication in heart failure (HF), often leading to unfavorable outcomes. Despite clinical significance, the published data are scarce. This study assessed prevalence, clinical associations and outcomes of CRAS among patients with HF attending the Benjamin Mkapa Hospital in Dodoma.
Methods
A prospective observational cohort study was carried out at cardiology clinic between August 2023 and April 2024. Adult patients aged ≥ 18 years confirmed with chronic heart failure were recruited by convenience (non‐probability) sampling. Age, sex, cigarettes smoking, dyslipidemia, obesity, New York Heart Association (NYHA) functional classification, hypertension, diabetes mellitus and iron deficiency were included as predictor variables. The primary outcome was CRAS and termed as exposed. All‐cause mortality, HF rehospitalisation, chronic kidney disease (CKD) progression and progressive anemia were secondary outcomes. Data were summarized by descriptive and inferential methods. Logistic regression was used to establish the clinical associations whereas, Cox proportional hazards regression was used to establish association of CRAS and secondary outcomes. A two‐tailed p ‐value ≤ 0.05 noted as statistical significance.
Results
This study involved 268 patients with a median age of 56.5 (IQR 18–92) years, 57.5% (154/268) were females. Prevalence of CRAS was 41.8% (112/268). Obesity (AOR 1.77; 95% CI, 1.02–3.06; p = 0.042), iron deficiency (AOR 2.36; 95% CI, 1.36–4.13; p = 0.002), NYHA category (class III/IV) (AOR 4.11; 95% CI, 2.35–7.16; p = 0.001) and diabetes mellitus (AOR 1.59; 95% CI, 1.03–2.70; p = 0.047) were clinically associated with unfavorable outcomes of CRAS. All‐cause mortality was high in CRAS (HR 1.96; 95% CI, 1.30–3.01; p = 0.001). Furthermore, CKD progression and progressive anemia were comparably similar to both cohorts (56.3% vs. 48.1%, p = 0.116) and (53.6% vs. 47.4%, p = 0.193), respectively.
Conclusion
The study showed that CRAS is highly prevalent and is associated with increased risk for all‐cause mortality. Obesity, iron deficiency, advanced NYHA functional stages and diabetes mellitus warrant special attention. This study was a single‐centered therefore, we propose a large multicentre study for generalizability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, School of Medicine and Dentistry University of Dodoma Dodoma Tanzania.
ORCID-Profile: Gidion Edwin, Baraka Alphonce
Zitieren
APA
Edwin, G., Alphonce, B., Meremo, A., & Meda, J. (2026). Prevalence, Clinical Associations, and Outcomes of Cardiorenal Anemia Syndrome Among Patients With Heart Failure Attending a Tertiary Hospital in Dodoma, Tanzania: A Prospective Observational Cohort Study. Health Science Reports, 9(7). https://doi.org/10.1002/hsr2.72809
Vancouver
Edwin G, Alphonce B, Meremo A, Meda J. Prevalence, Clinical Associations, and Outcomes of Cardiorenal Anemia Syndrome Among Patients With Heart Failure Attending a Tertiary Hospital in Dodoma, Tanzania: A Prospective Observational Cohort Study. Health Science Reports. 2026;9(7). doi:10.1002/hsr2.72809
BibTeX
@article{Edwin2026,
author = {Edwin, Gidion and Alphonce, Baraka and Meremo, Alfred and Meda, John},
title = {Prevalence, Clinical Associations, and Outcomes of Cardiorenal Anemia Syndrome Among Patients With Heart Failure Attending a Tertiary Hospital in Dodoma, Tanzania: A Prospective Observational Cohort Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {7},
doi = {10.1002/hsr2.72809}
}
EUVIMED